Source: Eur Respir J, 55 (2) 1901259; 10.1183/13993003.01259-2019
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Andrew D. Kerkhoff, Bianca Sossen, Charlotte Schutz, Elena Ivanova Reipold, Andre Trollip, Emmanuel Moreau, Samuel G. Schumacher, Rosie Burton, Amy Ward, Mark P. Nicol, Graeme Meintjes, Claudia M. Denkinger, Tobias Broger. Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV. Eur Respir J, 55 (2) 1901259; 10.1183/13993003.01259-2019

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients Source: Eur Respir J 2012; 40: 1211-1220 Year: 2012 Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Detection of TB by smear microscopy and GeneXpert MTB/RIF assay in non expectorating pulmonary TB suspects and pleural TB in high prevalent low income setting Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Utility of MPT64 antigen detection test for diagnosis of HIV coinfected extrapulmonary tuberculosis in Tanzania Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2012; 39: 163-171 Year: 2012 Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2011; 39: 163-171 Year: 2012 A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018 Year: 2019 Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis Source: Eur Respir J 2012; 40: 442-447 Year: 2012 A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India Source: Eur Respir J 2014; 44: 1090-1093 Year: 2014 Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Role of detection of lipoarabinomannan (LAM) in urine for diagnosis of tuberculosis in HIV patients; Egyptian experience Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006 Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study Source: Eur Respir J, 58 (5) 2003999; 10.1183/13993003.03999-2020 Year: 2021 Diagnosis of latent tuberculosis infection (LTBI) by quantiFERON®-TB gold test – QFT in homeless people in Poland Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Evaluation of the QuantiFERON-TB Gold in tube cut-off for diagnosing tuberculosis in HIV-infected and non-HIV infected individuals Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2012 Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis Source: Eur Respir J 2013; 42: 708-720 Year: 2013